AI Article Synopsis

  • The high mutation rate in humans may help explain the loss of certain genes linked to neurodevelopmental and psychiatric disorders.
  • A study using exome sequencing on ten individuals with unexplained mental retardation found unique de novo mutations in nine different genes.
  • Six of these mutations are likely pathogenic, suggesting that both de novo mutations and copy number variations play a significant role in causing mental retardation in the population.

Article Abstract

The per-generation mutation rate in humans is high. De novo mutations may compensate for allele loss due to severely reduced fecundity in common neurodevelopmental and psychiatric diseases, explaining a major paradox in evolutionary genetic theory. Here we used a family based exome sequencing approach to test this de novo mutation hypothesis in ten individuals with unexplained mental retardation. We identified and validated unique non-synonymous de novo mutations in nine genes. Six of these, identified in six different individuals, are likely to be pathogenic based on gene function, evolutionary conservation and mutation impact. Our findings provide strong experimental support for a de novo paradigm for mental retardation. Together with de novo copy number variation, de novo point mutations of large effect could explain the majority of all mental retardation cases in the population.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.712DOI Listing

Publication Analysis

Top Keywords

mental retardation
16
novo paradigm
8
paradigm mental
8
novo mutations
8
novo
7
mental
4
retardation
4
retardation per-generation
4
per-generation mutation
4
mutation rate
4

Similar Publications

The tRNA methyltransferase 1 (TRMT1) enzyme catalyzes the N2,N2-dimethylguanosine (m2,2G) modification in tRNAs. Intriguingly, vertebrates encode an additional tRNA methyltransferase 1-like (TRMT1L) paralog. Here, we use a comprehensive tRNA sequencing approach to decipher targets of human TRMT1 and TRMT1L.

View Article and Find Full Text PDF

The Genetics of Neurodevelopmental Disorders Lab in Padua provided a new intellectual disability (ID) Panel challenge for computational methods to predict patient phenotypes and their causal variants in the context of the Critical Assessment of the Genome Interpretation, 6th edition (CAGI6). Eight research teams submitted a total of 30 models to predict phenotypes based on the sequences of 74 genes (VCF format) in 415 pediatric patients affected by Neurodevelopmental Disorders (NDDs). NDDs are clinically and genetically heterogeneous conditions, with onset in infant age.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Fleni, Buenos Aires, Argentina.

Background: Down Syndrome (DS) is the most common genetic form of intellectual disability. In recent years, there has been a significant increase in the life expectancy of individuals with DS, currently reaching the age of 60 or over. However, it has been observed that as of age 40, these individuals experience higher risk of developing dementia, and almost all of them exhibit histopathological characteristics of Alzheimer's disease (AD) in their brains.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

University of Wisconsin-Madison, Madison, WI, USA.

Background: People with Down syndrome (DS) are genetically at-risk for Alzheimer's disease (AD). The age of symptomatic AD in DS varies (late-40s-70s). Lifestyle factors are theorized to explain some of this variability.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA; NYU Langone Health, New York, NY, USA.

Background: Clinical and preclinical evidence suggest that abnormal electrical activity strongly impacts outcomes in Alzheimer's disease (AD). Indeed, AD patients with interictal spikes (IIS) show faster cognitive decline than those without IIS. Furthermore, seizures in patients with AD have been suggested to accelerate disease progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!